Aguinaga-Ontoso, I.; Guillén-Aguinaga, S.; Guillén-Aguinaga, L.; Alas-Brun, R.; Aguinaga-Ontoso, E.; Rayón-Valpuesta, E.; Guillén-Grima, F.
Has COVID-19 Affected DTP3 Vaccination in the Americas? Vaccines 2024, 12, 238.
https://doi.org/10.3390/vaccines12030238
AMA Style
Aguinaga-Ontoso I, Guillén-Aguinaga S, Guillén-Aguinaga L, Alas-Brun R, Aguinaga-Ontoso E, Rayón-Valpuesta E, Guillén-Grima F.
Has COVID-19 Affected DTP3 Vaccination in the Americas? Vaccines. 2024; 12(3):238.
https://doi.org/10.3390/vaccines12030238
Chicago/Turabian Style
Aguinaga-Ontoso, Ines, Sara Guillén-Aguinaga, Laura Guillén-Aguinaga, Rosa Alas-Brun, Enrique Aguinaga-Ontoso, Esperanza Rayón-Valpuesta, and Francisco Guillén-Grima.
2024. "Has COVID-19 Affected DTP3 Vaccination in the Americas?" Vaccines 12, no. 3: 238.
https://doi.org/10.3390/vaccines12030238
APA Style
Aguinaga-Ontoso, I., Guillén-Aguinaga, S., Guillén-Aguinaga, L., Alas-Brun, R., Aguinaga-Ontoso, E., Rayón-Valpuesta, E., & Guillén-Grima, F.
(2024). Has COVID-19 Affected DTP3 Vaccination in the Americas? Vaccines, 12(3), 238.
https://doi.org/10.3390/vaccines12030238